DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Maxidex (Dexamethasone Ophthalmic) - Summary



0.1% (dexamethasone ophthalmic suspension)

MAXIDEX® 0.1% (dexamethasone ophthalmic suspension) is an adrenocortical steroid prepared as a sterile topical ophthalmic suspension.

MAXIDEX (DEXAMETHASONE) is indicated for the following:

Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical, radiation, or thermal burns, or penetration of foreign bodies.

See all Maxidex indications & dosage >>


Published Studies Related to Maxidex (Dexamethasone Ophthalmic)

A randomized clinical trial of the effects of submucosal dexamethasone after surgery for mandibular fractures. [2015]
mandibular fractures... CONCLUSION: The results of our study suggest that submucosal administration of

A multi-center, double-blind, randomized, placebo-controlled trial protocol to assess Traumeel injection vs dexamethasone injection in rotator cuff syndrome: the TRAumeel in ROtator cuff syndrome (TRARO) study protocol. [2015]
BACKGROUND: Shoulder pain is a common musculoskeletal symptom with a wide range of potential causes; however, the majority of conditions can be managed with conservative treatment... DISCUSSION: It is hoped that the results of this trial will expand the treatment options and evidence base available for the management of rotator cuff disease.

Comparison of local and intravenous dexamethasone for postoperative pain and recovery after tonsillectomy. [2015]
injection for postoperative pain and recovery after tonsillectomy... CONCLUSION: Local infiltration of dexamethasone was more effective than systemic

Effect of combined dexamethasone therapy with nebulized r-epinephrine or salbutamol in infants with bronchiolitis: A randomized, double-blind, controlled trial. [2014]
bronchodilators alone for the treatment of infants with bronchiolitis... CONCLUSIONS: This study adds to a body of evidence suggesting that

The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double-blind, placebo-controlled study. [2014]
block characteristics... CONCLUSIONS: Preoperative administration of IV and perineural dexamethasone

more studies >>

Clinical Trials Related to Maxidex (Dexamethasone Ophthalmic)

Dexamethasone in Lower Third Molar Surgery [Recruiting]
The aim of this randomized double-blind cross over clinical trial is to investigate effectiveness of different routes of applications (intramuscular and submucous at the site of surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and quality of life after lower third molar surgery.

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) [Recruiting]
The project was undertaking by Qilu Hospital of Shandong University and other 7 well-known hospitals in China. In order to report the efficacy and safety of different dose dexamethasone in treating the immune thrombocytopenia (ITP).

Dexamethasone for the Treatment of Established Postoperative Nausea and Vomiting [Recruiting]
Postoperative nausea and vomiting (PONV) are frequent after surgery and anaesthesia. Dexamethasone is widely used as antiemetic for the prevention of PONV. Little is known about the efficacy of antiemetic drugs for the treatment of established PONV symptoms. No single randomised trial has been published so far that tests the efficacy of dexamethasone for the treatment of established PONV symptoms. In this trial the investigators want to test the antiemetic efficacy of three different doses of intravenous dexamethasone for the treatment of established PONV symptoms. In adjunct protocols of this study the investigators aim to establish a novel method to quantify the anti-nausea efficacy of an antiemetic drug, to study pharmacogenetics of PONV, and to further our understanding on the smoking status as a predictive factor of PONV.

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane [Recruiting]
The purpose of this study is to evaluate the effect of dexamethasone intravitreal implant (Ozurdex) in combination with pars plana vitrectomy and membrane peeling for idiopathic epiretinal membrane (ERM).

Dexamethasone Therapy in VLBW Infants at Risk of CLD [Completed]
Infants who are on breathing support are often treated with steroids (dexamethasone); however, the best timing of therapy is not known. This trial looked at the benefits and hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in premature infants.

more trials >>

Reports of Suspected Maxidex (Dexamethasone Ophthalmic) Side Effects

Intraocular Pressure Increased (5)Corneal Thickening (3)Transplant Failure (2)Post Procedural Complication (2)Visual Acuity Reduced (2)Transplant Rejection (2)Corneal Opacity (2)Endophthalmitis (2)Corneal Decompensation (2)Lens Extraction (1)more >>

Page last updated: 2015-08-10

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017